SCHEMBL14933576

SCHEMBL14933576

O=c1c2ccncc2c2ncccc2n1-c1cccc(-c2ccccc2)c1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 8/20 0.43
KMT2A Q03164 3/20 0.38
MEN1 O00255 2/20 0.38
HSP90AA1 P07900 2/20 0.38
LOXL3 P58215 1/20 0.38
LOXL2 Q9Y4K0 1/20 0.38
PDE10A Q9Y233 1/20 0.38
CYP1A2 P05177 1/20 0.37
POLB P06746 1/20 0.37
CYP3A4 P08684 1/20 0.37
CYP2C9 P11712 1/20 0.37
CYP2C19 P33261 1/20 0.37
ALOX12 P18054 1/20 0.37
GAA P10253 1/20 0.36
MDM2 Q00987 1/20 0.36
FAAH O00519 1/20 0.36
ALDH1A1 P00352 1/20 0.36
PKM P14618 1/20 0.36
HTT P42858 1/20 0.36
ATM Q13315 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21636016 0.91 MAPT (0.41) MAPTKMT2AMEN1HSP90AA1LOXL3
SCHEMBL21636019 0.83 IDO1 (0.37) MAPTLOXL3LOXL2CYP1A2CYP2C9
SCHEMBL14933478 0.82 KMT2A (0.47) MAPTKMT2AMEN1HSP90AA1LOXL3
SCHEMBL14933551 0.81 TOP1 (0.39) MAPTKMT2AMEN1HSP90AA1ALOX12
SCHEMBL21624463 0.78 MAPT (0.42) MAPTKMT2AMEN1HSP90AA1PDE10A
SCHEMBL15436331 0.77 GRM5 (0.39) MAPTHSP90AA1PDE10ACYP2C19FAAH
SCHEMBL31273211 0.77 MAOA (0.39) MAPTHSP90AA1CYP1A2ATMGRM5
SCHEMBL14933505 0.77 MAPT (0.44) MAPTKMT2AMEN1HSP90AA1POLB
SCHEMBL15855400 0.76 KDM4E (0.39) MAPTCYP1A2CYP3A4CYP2C19ALDH1A1
SCHEMBL804769 0.76 BTK (0.37) MAPTCYP1A2CYP3A4CYP2C19ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20200216391-A1 COMPOSITION FOR ORGANIC ELECTRONIC DEVICES MERCK PATENT GMBH (DE) 2020-07-09 US disclosed
US-9337430-B2 Organic electroluminescent device MERCK PATENT GMBH (DE) 2016-05-10 US disclosed
US-9337430-B2 Organic electroluminescent device MERCK PATENT GMBH (DE) 2016-05-10 US disclosed
EP-2773721-B1 ORGANIC ELECTROLUMINESCENT DEVICE MERCK PATENT GMBH (DE) 2015-11-25 EP disclosed
US-20140249308-A1 ORGANIC ELECTROLUMINESCENT DEVICE MERCK PATENT GMBH (DE) 2014-09-04 US disclosed
US-20140249308-A1 ORGANIC ELECTROLUMINESCENT DEVICE MERCK PATENT GMBH (DE) 2014-09-04 US disclosed
WO-2013064206-A1 ORGANIC ELECTROLUMINESCENT DEVICE MERCK PATENT GMBH (DE) 2013-05-10 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200216391-A1 COMPOSITION FOR ORGANIC ELECTRONIC DEVICES SLCO2B1, SLCO4C1, SLCO2A1 MAPT 1459/4885KMT2A 3888/4885MEN1 2556/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.